Raltegravir Tablets USP, 600 mg are indicated in combination with other antiretroviral agents for the treatment of human ...

AstraZeneca’s presence in South Africa has become a driving force in global health research, contributing significantly to respiratory, cardiovascular, and oncology therapeutic areas. The ...

Raltegravir Tablets USP, 600 mg are indicated in combination with other antiretroviral agents for the treatment of human ...

With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...

Gilead stock surges after Q3 earnings beat estimates and raised FY 2024 guidance, with strong HIV drug sales and analyst ...

"China market is one of the most attractive markets for Edwards," said Leo Tam, senior director of the business unit of Transcatheter Aortic Valve Replacement, Edwards Lifesciences China, citing a lot ...

Welcome to the Merck & Company Q3 sales and earnings conference call. [Operator instructions] This call is being recorded.

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...

Herpesviruses are common co-pathogens in individuals infected with human immunodeficiency virus (HIV). Herpes simplex virus ...

Are you a print subscriber? Activate your account. By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ...

The first anti-diarrheal drug for HIV /AIDS patients has been approved by the FDA for use in the United States. Fulyzag (crofelemer) has been approved to relieve symptoms of diarrhea in HIV / AIDS ...